1 A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study

2 Intensive intervention can lead to a treatment holiday from biological DMARDs in patients with rheumatoid arthritis

3 Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial

4 Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis

5 [Rheumatoid arthritis as a connective tissue disease]

6 Early, Incomplete, or Preclinical Autoimmune Systemic Rheumatic Diseases and Pregnancy Outcome

7 [Rheumatoid arthritis in elderly people]

8 Diastolic dysfunction in rheumatoid arthritis patients with low disease activity

9 [Early reumatoid arthritis]

10 The impact of the current epidemiology of pediatric musculoskeletal infection on evaluation and treatment guidelines

11 The "Treat to Target" Approach to Rheumatoid Arthritis

12 [Clinical and ultrasound assessment of the disease activity in patients with rheumatoid arthritis]

13 Cryptotanshinone induces reactive oxygen species‑mediated apoptosis in human rheumatoid arthritis fibroblast‑like synoviocytes

14 Gender Differences in Cardiovascular Risk Profile in Rheumatoid Arthritis Patients with Low Disease Activity

15 [Discontinuation or tapering strategies of biologics in rheumatoid arthritis in remission]

16 Cardiovascular system changes in rheumatoid arthritis patients with continued low disease activity

17 Prospective assessment of cardiovascular risk parameters in patients with rheumatoid arthritis

18 Relationship between the effect of cyclophosphamide on adjuvant arthritis severity, skin allograft rejection and spleen cell cytotoxic activity in rats

19 The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis

20 [Hemangioblastoma associated with syringomyelia and syringobulbia in a patient with rheumatoid arthritis]

21 Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy

22 Baricitinib for the treatment of rheumatoid arthritis and systemic lupus erythematosus: a 2019 update

23 Alleviation of collagen-induced arthritis by the benzoxathiole derivative BOT-4-one in mice: Implication of the Th1- and Th17-cell-mediated immune responses.

24 Quality of life in psoriatic arthritis patients-association with disease activity and diagnostic delay time

25 Impact of psychological factors on subjective disease activity assessments in patients with severe rheumatoid arthritis.

26 Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.

27 High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.

28 Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.

29 Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk.

30 PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population.

31 Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13.

32 A Comparative Study of Interleukin 6, Inflammatory Markers, Ferritin, and Hematological Profile in Rheumatoid Arthritis Patients with Anemia of Chronic Disease and Iron Deficiency Anemia

33 Galectin-1, -4, and -7 Were Associated with High Activity of Disease in Patients with Rheumatoid Arthritis

34 Concordance between the Different Cardiovascular Risk Scores in People with Rheumatoid Arthritis and Psoriasis Arthritis

35 Medication Adherence and Coping Strategies in Patients with Rheumatoid Arthritis: A Cross-Sectional Study

36 Occipital and external acoustic meatus to axis angle: a useful predictor of oropharyngeal space in rheumatoid arthritis patients with atlantoaxial subluxation.

37 Association between plasminogen activator inhibitor‑1 (PAI-1) 4G/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis : A meta-analysis.

38 QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS - A PRELIMINARY STUDY.

39 Vitamin D Receptor Polymorphism and DHCR7 Contribute to the Abnormal Interplay Between Vitamin D and Lipid Profile in Rheumatoid Arthritis

40 Renal function and cardiovascular risk in rheumatoid arthritis

41 Respiratory viral infections and the risk of rheumatoid arthritis.

42 Prevalence of methotrexate intolerance among patients with rheumatoid arthritis using the Arabic version of the methotrexate intolerance severity score.

43 Crosstalk between Fas and S1P<inf>1</inf> signaling via NF-kB in osteoclasts controls bone destruction in the TMJ due to rheumatoid arthritis

44 Three-dimensional assessment of facial morphology in children and adolescents with juvenile idiopathic arthritis and moderate to severe TMJ involvement using 3D surface scans

45 Assessment of interstitial lung disease among black rheumatoid arthritis patients.

46 Potential mechanisms linking periodontitis to rheumatoid arthritis.

47 Mayaro Virus Infects Human Chondrocytes and Induces the Expression of Arthritis-Related Genes Associated with Joint Degradation.

48 Therapeutic benefits of Indole-3-Carbinol in adjuvant-induced arthritis and its protective effect against methotrexate induced-hepatic toxicity.

49 Machine-learning based knowledge discovery in rheumatoid arthritis related registry data to identify predictors of persistent pain.

50 Characterization of rheumatoid arthritis subtypes using symptom profiles, clinical chemistry and metabolomics measurements.

51 Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis.

52 Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis.

53 Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis.

54 Effectiveness of subcutaneously administered methotrexate in patients with rheumatoid arthritis.

55 Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: multi-center retrospective descriptive study.

56 Efficacy and Safety of Multiple Dosages of Fostamatinib in Adult Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.

57 No increase in the risk of autism spectrum disorder in children born to mothers with systemic lupus erythematosus and rheumatoid arthritis

58 Collagen II-primed Foxp3 Transduced T Cells Ameliorate Collagen-induced Arthritis in Rats: The Effect of Antigenic Priming on T Regulatory Cell Function.

59 Investigation of the cytokine response to NF-ΚB decoy oligonucleotide coated polysaccharide based nanoparticles in rheumatoid arthritis in vitro models

60 Opuntioside, opuntiol and its metallic nanoparticles attenuate adjuvant-induced arthritis: Novel suppressors of Toll-like receptors -2 and -4.

61 Proteomics Approach for the Discovery of Rheumatoid Arthritis Biomarkers Using Mass Spectrometry.

62 A case study applying a novel approach to estimate the social impact of a medical innovation - the use of secukinumab for psoriatic arthritis in Germany.

63 Comparison of oral versus parenteral methotrexate in the treatment of rheumatoid arthritis: A meta-analysis.

64 Nigella sativa fixed oil as alternative treatment in management of pain in arthritis rheumatoid.

65 Salivary gland involvement and oxidative stress in juvenile idiopathic arthritis: Novel observation in oligoarticular-type patients

66 Salivary gland involvement in rheumatoid arthritis and its relationship to induced oxidative stress

67 Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study.

68 Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review.

69 Clinico-genetic model to predict methotrexate intolerance in rheumatoid arthritis.

70 Chikungunya arthritis.

71 The potential value of rapid, cloud-enabled onsite testing for the diagnosis of rheumatoid arthritis in the United States.

72 First Validation of the Full PROMIS Pain Interference and Pain Behavior Item Banks in Patients with Rheumatoid Arthritis.

73 Neonatal septic arthritis: Indian perspective.

74 The Influence of Allowable Refill Gaps on Detecting Long-Term Opioid Therapy: An Analysis of Population-Based Administrative Dispensing Data Among Patients with Knee Arthritis Awaiting Total Knee Arthroplasty.

75 Acute gouty arthritis and rapidly progressive renal failure as manifestation of multiple myeloma: clinical case description

76 Analysis of intestinal immunity and flora in a collagen-induced mouse arthritis model: differences during arthritis progression.

77 Mobile Health Features Supporting Self-Management Behavior in Patients With Chronic Arthritis: Mixed-Methods Approach on Patient Preferences.

78 Additive effects of inhibiting both mTOR and glutamine metabolism on the arthritis in SKG mice

79 Сase Report of Acute Toxic Imatinib-induced Hepatitis in a Patient with Chronic Myeloid Leukemia, Sulfa Allergy, and Rheumatoid Arthritis.

80 Are we really what we eat? Nutrition and its role in the onset of rheumatoid arthritis.

81 Linking systemic angiogenic markers to synovial vascularization in rheumatoid arthritis.

82 The Microbiome in Psoriasis and Psoriatic Arthritis: The Skin Perspective.

83 Adjunctive vitamin D for the treatment of active juvenile idiopathic arthritis: An open-label, prospective, randomized controlled trial.

84 An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis

85 Analgesic and antiinflammatory effects of dipyrone in rat adjuvant arthritis model.

86 Use of FDA-Approved Medications: Biologics for Psoriatic Arthritis in Patients at an Urban Outpatient Rheumatology Clinic.

87 A criterion-based approach to systematic and transparent comparative effectiveness: a case study in psoriatic arthritis.

88 Methotrexate Restores CD73 Expression on Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis Patients and May Contribute to Its Anti-Inflammatory Effect through Ado Production.

89 Therapeutic effect of a novel histone deacetylase 6 inhibitor, CKD-L, on collagen-induced arthritis in vivo and regulatory T cells in rheumatoid arthritis in vitro

90 What potential do magnetic iron oxide nanoparticles have for the treatment of rheumatoid arthritis?

91 Enthesitis and its relationship with disease activity, functional status, and quality of life in psoriatic arthritis: a multi-center study.

92 Regulation of T Cell Function by Reactive Nitrogen and Oxygen Species in Collagen-Induced Arthritis.

93 Synovial tissue quantitative proteomics analysis reveals paeoniflorin decreases LIFR and ASPN proteins in experimental rheumatoid arthritis.

94 Sequential alterations in catabolic and anabolic gene expression parallel pathological changes during progression of monoiodoacetate-induced arthritis.

95 Role of Interleukin 6 Inhibitors in the Management of Rheumatoid Arthritis.

96 Effect of Moxibustion on HIF-1 and VEGF Levels in Patients with Rheumatoid Arthritis.

97 Long-term results of modified ligament reconstruction and tendon interposition for thumb basal joint arthritis.

98 Dose-Dependent Efficacy of Gold Clusters on Rheumatoid Arthritis Therapy.

99 Impact of collagen-induced arthritis on the pharmacokinetic disposition of voriconazole, a widely used antifungal agent: in vitro and in vivo investigations in DBA/1J mice.

100 Synovial-Fluid miRNA Signature for Diagnosis of Juvenile Idiopathic Arthritis.

101 Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.

Keyword Connections

Journals

Research Groups

Bibliographies